Precigen Announces Clearance of IND to Initiate Phase 1/1b Study

PGEN: Precigen, Inc.
2021-10-26 08:05:00
Precigen Announces Clearance of IND to Initiate Phase 1/1b Study for PRGN-3007 UltraCAR-T® in Advanced ROR1+ Hematological and Solid Tumors
Beyond Technical Analysis

免责声明